The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 29, 2021

Filed:

Dec. 16, 2016
Applicants:

The Regents of the University of Michigan, Ann Arbor, MI (US);

The University of Kansas, Lawrence, KS (US);

Inventors:

Steven R. Buchman, Ann Arbor, MI (US);

Mark Cohen, Ann Arbor, MI (US);

Alexis Donneys, Ann Arbor, MI (US);

Noah Nelson, Ann Arbor, MI (US);

Laird Forrest, Lawrence, KS (US);

Ti Zhang, Lawrence, KS (US);

Qiuhong Yang, Lawrence, KS (US);

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/69 (2017.01); A61P 19/00 (2006.01); A61P 19/08 (2006.01); A61K 9/51 (2006.01); A61L 27/50 (2006.01); A61K 47/61 (2017.01); A61K 31/16 (2006.01); A61L 27/20 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6939 (2017.08); A61K 9/5169 (2013.01); A61K 31/16 (2013.01); A61K 47/61 (2017.08); A61L 27/20 (2013.01); A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); A61P 19/00 (2018.01); A61P 19/08 (2018.01); A61L 2300/412 (2013.01); A61L 2300/624 (2013.01); A61L 2300/626 (2013.01); A61L 2400/12 (2013.01); A61L 2430/02 (2013.01);
Abstract

The present invention relates to novel therapeutic nanoparticles. In particular, the present invention is directed to nanoparticles associated (e.g., complexed, conjugated, encapsulated, absorbed, adsorbed, admixed) with angiogenesis-activating-agents, methods of synthesizing the same, devices or compositions comprising such nanoparticles, as well as systems and methods utilizing the nanoparticles (e.g., in therapeutic settings for enhancing and/or activating angiogenesis at targeted tissue region).


Find Patent Forward Citations

Loading…